600572.SHG Zhejiang CONBA Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
4.35 CNY
Close of Nov 5, 2026
3.77 5.17
Market cap
CNY 11.1B
P/E
24.2x
P/B
1.53x
ROE
10.4%
Dividend yield
3.47%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600572.SHG undervalued?

Graham number
Price4.35
Graham value3.40
Premium28.0%

600572.SHG trades 28.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang CONBA Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang CONBA Pharmaceutical Co Ltd yet.

Zhejiang CONBA Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang CONBA Pharmaceutical Co Ltd

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-…

Full company profile